Kennedy's Contentious HHS Confirmation Hearing Highlights Deep Political Divides
Robert F. Kennedy Jr."s Senate confirmation hearing for HHS Secretary sparked intense debate over his anti-vaccine stance, abortion views, and conflicts of interest, raising concerns about his suitability for the position and the future direction of US health policy.
Kennedy's Contentious HHS Confirmation Hearing Highlights Deep Political Divides
Robert F. Kennedy Jr."s Senate confirmation hearing for HHS Secretary sparked intense debate over his anti-vaccine stance, abortion views, and conflicts of interest, raising concerns about his suitability for the position and the future direction of US health policy.
Progress
28% Bias Score
Oncologist's Methylene Blue Cancer Claim Sparks Warnings and Investigation
Dr. Laurent Schwartz, a Parisian oncologist, controversially claims methylene blue cures cancer, a claim rejected by the scientific community, leading to investigations and warnings against its use due to its inefficacy and potential harm.
Oncologist's Methylene Blue Cancer Claim Sparks Warnings and Investigation
Dr. Laurent Schwartz, a Parisian oncologist, controversially claims methylene blue cures cancer, a claim rejected by the scientific community, leading to investigations and warnings against its use due to its inefficacy and potential harm.
Progress
48% Bias Score
18th-Century Trial Proposal Foreshadowed Modern Clinical Research
New research suggests Francis Hauksbee the Younger's 1743 proposal for a controlled clinical trial, though never conducted, may have influenced James Lind's 1747 scurvy trial, marking a pivotal moment in the evolution of modern clinical research.
18th-Century Trial Proposal Foreshadowed Modern Clinical Research
New research suggests Francis Hauksbee the Younger's 1743 proposal for a controlled clinical trial, though never conducted, may have influenced James Lind's 1747 scurvy trial, marking a pivotal moment in the evolution of modern clinical research.
Progress
28% Bias Score
NIH's $1.8 Billion Long COVID Investment: Slow Progress Fuels Patient Frustration
The NIH has invested $1.8 billion in long COVID research, yet millions of patients lack effective treatments, prompting calls for faster clinical trials and FDA approvals; research focuses on understanding the disease's mechanisms before large-scale trials.
NIH's $1.8 Billion Long COVID Investment: Slow Progress Fuels Patient Frustration
The NIH has invested $1.8 billion in long COVID research, yet millions of patients lack effective treatments, prompting calls for faster clinical trials and FDA approvals; research focuses on understanding the disease's mechanisms before large-scale trials.
Progress
60% Bias Score
Record-Breaking Philanthropy in Higher Education: 2024 Mega-Gifts
In 2024, over a dozen higher education institutions received mega-gifts exceeding $100 million each, totaling over $5 billion, with medical education and research, financial aid, and minority-serving institutions as major beneficiaries.
Record-Breaking Philanthropy in Higher Education: 2024 Mega-Gifts
In 2024, over a dozen higher education institutions received mega-gifts exceeding $100 million each, totaling over $5 billion, with medical education and research, financial aid, and minority-serving institutions as major beneficiaries.
Progress
28% Bias Score
AI Blood Tests Show Promise in Early Ovarian Cancer Detection
New AI-powered blood tests are showing promise in detecting ovarian cancer five years before symptoms appear, improving diagnosis and survival rates; AI also speeds up pneumonia diagnosis and antibiotic selection, reducing costs and improving patient care.
AI Blood Tests Show Promise in Early Ovarian Cancer Detection
New AI-powered blood tests are showing promise in detecting ovarian cancer five years before symptoms appear, improving diagnosis and survival rates; AI also speeds up pneumonia diagnosis and antibiotic selection, reducing costs and improving patient care.
Progress
44% Bias Score
NIH Clarifies Research Continuity Amidst Communications Pause
NIH Acting Director Matthew Memoli issued a memo clarifying that clinical trials and essential research can proceed despite a temporary communications pause ordered by President Trump, but new grant reviews and procurements for new studies are temporarily halted.
NIH Clarifies Research Continuity Amidst Communications Pause
NIH Acting Director Matthew Memoli issued a memo clarifying that clinical trials and essential research can proceed despite a temporary communications pause ordered by President Trump, but new grant reviews and procurements for new studies are temporarily halted.
Progress
44% Bias Score
18th-Century Trial Proposal Foreshadowed Modern Clinical Research
New research suggests Francis Hauksbee the Younger's 1743 proposal for a controlled clinical trial design, though never conducted, may have influenced James Lind's 1747 scurvy trial, marking a critical early step in the evolution of evidence-based medicine.
18th-Century Trial Proposal Foreshadowed Modern Clinical Research
New research suggests Francis Hauksbee the Younger's 1743 proposal for a controlled clinical trial design, though never conducted, may have influenced James Lind's 1747 scurvy trial, marking a critical early step in the evolution of evidence-based medicine.
Progress
24% Bias Score
University of Turin to Invest €100 Million in New Medical School Building
The University of Turin will invest over €100 million in a new 30,000 square meter university building, the Domus universitaria, to accommodate approximately 10,000 students in medical fields, located next to the new Parco della Salute hospital in Turin, Italy. The increased cost reflects rising mat...
University of Turin to Invest €100 Million in New Medical School Building
The University of Turin will invest over €100 million in a new 30,000 square meter university building, the Domus universitaria, to accommodate approximately 10,000 students in medical fields, located next to the new Parco della Salute hospital in Turin, Italy. The increased cost reflects rising mat...
Progress
40% Bias Score
AI-Powered Dietary Study to Reveal Personalized Weight Management Strategies in 2025
A major US study analyzing data from over 8,000 adults will publish initial results in early 2025, utilizing AI to analyze genetic factors, gut microbiome, lifestyle, and prior illnesses to improve predictions of individual responses to diets and long-term dietary changes.
AI-Powered Dietary Study to Reveal Personalized Weight Management Strategies in 2025
A major US study analyzing data from over 8,000 adults will publish initial results in early 2025, utilizing AI to analyze genetic factors, gut microbiome, lifestyle, and prior illnesses to improve predictions of individual responses to diets and long-term dietary changes.
Progress
40% Bias Score
US Companies to Begin Clinical Trials for Pig Organ Transplants in 2025
Facing a critical organ shortage, two US companies aim to start clinical trials in 2025 using genetically modified pig organs for transplantation, offering hope to patients like Alex Berrios who need transplants but lack compatible human donors.
US Companies to Begin Clinical Trials for Pig Organ Transplants in 2025
Facing a critical organ shortage, two US companies aim to start clinical trials in 2025 using genetically modified pig organs for transplantation, offering hope to patients like Alex Berrios who need transplants but lack compatible human donors.
Progress
48% Bias Score
Boston Scientific's Use of Unclaimed Bodies Sparks Ethical Debate and Policy Changes
Boston Scientific, a major medical technology company, used at least 25 unclaimed bodies for training purposes, prompting internal debate and policy changes after an NBC News investigation revealed the practice; the company has since severed ties with the provider and updated its policies to require...
Boston Scientific's Use of Unclaimed Bodies Sparks Ethical Debate and Policy Changes
Boston Scientific, a major medical technology company, used at least 25 unclaimed bodies for training purposes, prompting internal debate and policy changes after an NBC News investigation revealed the practice; the company has since severed ties with the provider and updated its policies to require...
Progress
52% Bias Score